Brief: DBP: MoU regarding possible licensing agreement on development of Temodex
05/04/2017 12:51
April 5 (Reuters) - Double Bond Pharmaceutical
International AB (publ) DBPHAb.ST :
* Signed a "Memorandum of Understanding" with international
partner regarding a possible licensing agreement on development
of Temodex
* Hopes to enter into a license agreement for Temodex with
this partner at latest during Q3 2017
Source text: http://bit.ly/2oCrO1S
Further company coverage: DBPHAb.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University